Skip to main navigation Skip to search Skip to main content

Researchers from Roswell Park Comprehensive Cancer Center Report on Findings in Adenocarcinoma (Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II ...)

  • Yu Fujiwara

Press/Media

Period24 Apr 2025

Media coverage

1

Media coverage

  • TitleResearchers from Roswell Park Comprehensive Cancer Center Report on Findings in Adenocarcinoma (Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II ...)
    Media name/outletClinical Trials Daily
    Country/TerritoryUnited States
    Date24/04/25
    PersonsYu Fujiwara